pyrrolidonecarboxylic acid has been researched along with Neutropenia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bazari, H; Forman, JP; Humphreys, BD; Magee, CC; Seifter, J; Zandi-Nejad, K | 1 |
Binder, KA; Moser, MH; Paukovits, JB; Paukovits, WR | 2 |
Moser, MH; Paukovits, JB; Paukovits, WR; Rutter, R | 1 |
1 review(s) available for pyrrolidonecarboxylic acid and Neutropenia
Article | Year |
---|---|
The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cytarabine; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Mice; Neutropenia; Oligopeptides; Polymers; Pyrrolidonecarboxylic Acid | 1990 |
3 other study(ies) available for pyrrolidonecarboxylic acid and Neutropenia
Article | Year |
---|---|
Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.
Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Adult; Analgesics, Non-Narcotic; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Candidiasis; Chlorides; Cytarabine; Etoposide; Fatal Outcome; Fever; Humans; Ifosfamide; Kidney Tubular Necrosis, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Neutropenia; Polycystic Kidney, Autosomal Dominant; Pyrrolidonecarboxylic Acid; Salvage Therapy; Systemic Inflammatory Response Syndrome | 2005 |
Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.
Topics: Animals; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Mice; Mice, Inbred BALB C; Mustard Compounds; Myeloproliferative Disorders; Neutropenia; Oligopeptides; Pyrrolidonecarboxylic Acid | 1991 |
Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage.
Topics: Animals; Cell Division; Colony-Forming Units Assay; Cytarabine; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Kinetics; Mice; Mice, Inbred BALB C; Neutropenia; Oligopeptides; Pyrrolidonecarboxylic Acid | 1991 |